{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:27:28Z","timestamp":1770978448438,"version":"3.50.1"},"reference-count":51,"publisher":"Japan Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1507\/endocrj.ej18-0348","type":"journal-article","created":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T22:03:47Z","timestamp":1567461827000},"page":"1083-1091","source":"Crossref","is-referenced-by-count":11,"title":["Flow cytometric, gene rearrangement, and karyotypic analyses of 110 cases of primary thyroid lymphoma: a single-institutional experience in Japan"],"prefix":"10.1507","volume":"66","author":[{"given":"Ayana","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Kuma Hospital, Kobe, Hyogo 650-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyoshi","family":"Hirokawa","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Hyogo 650-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Higashiyama","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kuma Hospital, Kobe, Hyogo 650-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Fukata","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kuma Hospital, Kobe, Hyogo 650-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nami","family":"Takada","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Faculty of Medicine, Oita University, Yufu, Oita 879-5593, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshitetsu","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Hyogo 650-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Kuma","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Hyogo 650-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Miyauchi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kuma Hospital, Kobe, Hyogo 650-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","unstructured":"1 D\u00fcndar HZ, Sarkut P, Kirdak T, Korun N (2016) Primary thyroid lymphoma. Ulus Cerrahi Derg 32: 75\u201377."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Ruggiero FP, Frauenhoffer E, Stack BC Jr (2005) Thyroid lymphoma: a single institution\u2019s experience. Otolaryngol Head Neck Surg 133: 888\u2013896.","DOI":"10.1016\/j.otohns.2005.07.040"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3 Ha CS, Shadle KM, Medeiros LJ, Wilder RB, Hess MA, et al. (2001) Localized non-Hodgkin lymphoma involving the thyroid gland. Cancer 91: 629\u2013635.","DOI":"10.1002\/1097-0142(20010215)91:4<629::AID-CNCR1045>3.0.CO;2-Q"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Sasai K, Yamabe H, Haga H, Tsutsui K, Dodo Y, et al. (1996) Non-Hodgkin\u2019s lymphoma of the thyroid. Acta Oncol 35: 457\u2013462.","DOI":"10.3109\/02841869609109922"},{"key":"5","unstructured":"5 Rasbach DA, Mondschein MS, Harris NL, Kaufman DS, Wang CA (1985) Malignant lymphoma of the thyroid gland: a clinical and pathologic study of 20 cases. Surgery 98: 1166\u20131170."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Hamburger JI, Miller JM, Kini SR (1983) Lymphoma of the thyroid. Ann Intern Med 99: 685\u2013693.","DOI":"10.7326\/0003-4819-99-5-685"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Devine RM, Edis AJ, Banks PM (1981) Primary lymphoma of the thyroid: a review of the Mayo Clinic experience through 1978. World J Surg 5: 33\u201338.","DOI":"10.1007\/BF01657831"},{"key":"8","unstructured":"8 Kato I, Tajima K, Suchi T, Aozasa K, Matsuzuka F, et al. (1985) Chronic thyroiditis as a risk factor of B-cell lymphoma in the thyroid gland. Jpn J Cancer Res 76: 1085\u20131090."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Holm LE, Blomgren H, Lowhagen T (1985) Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 312: 601\u2013604.","DOI":"10.1056\/NEJM198503073121001"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Walsh S, Lowery AJ, Evoy D, McDermott EW, Prichard RS (2013) Thyroid lymphoma: recent advances in diagnosis and optimal management strategies. Oncologist 18: 994\u20131003.","DOI":"10.1634\/theoncologist.2013-0036"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Stein SA, Wartofsky L (2013) Primary thyroid lymphoma: a clinical review. J Clin Endocrinol Metab 98: 3131\u20133138.","DOI":"10.1210\/jc.2013-1428"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Watanabe N, Noh JY, Narimatsu H, Takeuchi K, Yamaguchi T, et al. (2011) Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24,553 patients with Hashimoto\u2019s disease. Br J Haematol 153: 236\u2013243.","DOI":"10.1111\/j.1365-2141.2011.08606.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Derringer GA, Thompson LD, Frommelt RA, Bijwaard KE, Heffess CS, et al. (2000) Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol 24: 623\u2013639.","DOI":"10.1097\/00000478-200005000-00001"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Thieblemont C, Mayer A, Dumontet C, Barbier Y, Callet-Bauchu E, et al. (2002) Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrin Metab 87: 105\u2013111.","DOI":"10.1210\/jcem.87.1.8156"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Bernicot I, Douet-Guilbert N, Le Bris MJ, Herry A, Morel F, et al. (2007) Molecular cytogenetics of IGH rearrangements in non-Hodgkin B-cell lymphoma. Cytogenet Genome Res 118: 345\u2013352.","DOI":"10.1159\/000108319"},{"key":"16","unstructured":"16 Bernicot I, Douet-Guilbert N, Le Bris MJ, Morice P, Abgrall JF, et al. (2005) Characterization of IGH rearrangements in non-Hodgkin\u2019s B-cell lymphomas by fluorescence <i>in situ<\/i> hybridization. Anticancer Res 25: 3179\u20133182."},{"key":"17","unstructured":"17 Morse EE, Yamase HT, Greenberg BR, Sporn J, Harshaw SA, et al. (1994) The role of flow cytometry in the diagnosis of lymphoma: a critical analysis. Ann Clin Lab Sci 24: 6\u201311."},{"key":"18","unstructured":"18 Pirc-Danoewinata H, Chott A, Onderka E, Drach J, Schl\u00f6gl E, et al. (1994) Karyotyoe and prognosis in non-Hodgkin lymphoma. Leukemia 8: 1929\u20131939."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Hirokawa M, Kudo T, Ota H, Suzuki A, Kobayashi K, et al. (2017) Preoperative diagnostic algorithm of primary thyroid lymphoma using ultrasound, aspiration cytology, and flow cytometry. Endocr J <b>64<\/b>: 859\u2013865.","DOI":"10.1507\/endocrj.EJ17-0111"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Aamot HV, Micci F, Holte H, Delabie J, Heim S (2005) G-banding and molecular cytogenetic analyses of marginal zone lymphoma. Br J Haematol 130: 890\u2013901.","DOI":"10.1111\/j.1365-2141.2005.05706.x"},{"key":"21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cancergencyto.2004.02.003","volume":"155","author":"M Yoshimoto","year":"2004","unstructured":"21 Yoshimoto M, Maruyama Y, Satoh Y, Takahashi T, Tsujisaki M (2004) A malignant lymphoma of the thyroid with trisomy 21 as the sole chromosomal anomaly. Cancer Genetics 155: 87\u201388.","journal-title":"Cancer Genetics","ISSN":"https:\/\/id.crossref.org\/issn\/2210-7762","issn-type":"print"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Sekiguchi Y, Shimada A, Imai H, Wakabayashi M, Sugimoto K, et al. (2014) A case of advanced primary thyroid double-hit B cell lymphoma in which complete remission has been maintained after high-dose chemotherapy and autologous peripheral blood stem cell transplantation performed during the second remission, with a review of the literature. Indian J Hematol Blood Transfus 30: 166\u2013173.","DOI":"10.1007\/s12288-013-0312-x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Siddiqui UM, Rao SN, Galera PK, Islam N, Torres MS (2017) Mantle cell lymphoma in the thyroid: a rare presentation. Case Rep Pathol 2017: 6749801.","DOI":"10.1155\/2017\/6749801"},{"key":"24","unstructured":"24 (2013) Neoplasm. In: Shaffer LG, McGowan-Jordan J, Schmid M (eds), ISCN (2013) An international system for human cytogenetic nomenclature (1st). Karger, Basel, Freiburg: 88."},{"key":"25","unstructured":"25 Thompson LDR, Roth CG (2012) Primary thyroid lymphoma. In: Nikiforov YE, Biddinger PW, Thompson LDR (eds) Diagnostic pathology and molecular genetics of the thyroid (2<sup>nd<\/sup>). Lippincott Williams &amp; Wilkins, Philadelphia: 377\u2013393."},{"key":"26","unstructured":"26 Chen C, Yang Y, Jin L, Dong L, Zhang X, et al. (2014) Primary thyroid T-lymphoblastic lymphoma: a case report and review of the literature. Int J Clin Exp Pathol 7: 443\u2013450."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Hwang, YC, Kim TY, Kim WB, Shong YK, Yi KH, et al. (2009) Clinical characteristics of primary thyroid lymphoma in Koreans. Endocr J 56: 399\u2013405.","DOI":"10.1507\/endocrj.K08E-355"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28 Pedersen RK, Pedersen NT (1996) Primary non-Hodgkin\u2019s lymphoma of the thyroid gland: a population based study. Histopathology 28: 25\u201332.","DOI":"10.1046\/j.1365-2559.1996.268311.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Matsuzuka F, Fukata S, Kuma K, Miyauchi A, Kakudo K, et al. (1998) Gene rearrangement of immunoglobulin as a marker of thyroid lymphoma. World J Surg 22: 558\u2013561.","DOI":"10.1007\/s002689900434"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Hunt KE, Reichard KK (2008) Diffuse large B-cell lymphoma. Arch Pathol Lab Med 132: 118\u2013124.","DOI":"10.5858\/2008-132-118-DLBL"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Boonyaarunnate T, Olson MT, Ali SZ (2013) Imapct of flow cytometry in thyroid cytopathology. Acta Cytol 57: 562\u2013566.","DOI":"10.1159\/000354432"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Stacchini A, Pacchioni D, Demurtas A, Aliberti S, Cassenti A, et al. (2015) Utility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas. Cytometry B Clin Cytom 88: 320\u2013329.","DOI":"10.1002\/cyto.b.21204"},{"key":"33","unstructured":"33 Geary WA, Frierson HF, Innes DJ, Normansell DE (1993) Quantitative criteria for clonality in the diagnosis of B-cell non-Hodgkin\u2019s lymphoma by flow cytometry. Mod Pathol 6: 155\u2013161."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Swart GJ, Wright C, Brundyn K, Mansvelt E, du Plessis M, et al. (2007) Fine needle aspiration biopsy and flow cytometry in the diagnosis of lymphoma. Transfus Apher Sci 37: 71\u201379.","DOI":"10.1016\/j.transci.2007.06.001"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Kaleem Z (2006) Flow cytometric analysis of lymphomas: current status and usefulness. Arch Pathol Lab Med 130: 1850\u20131858.","DOI":"10.5858\/2006-130-1850-FCAOLC"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Saxena A, Alport EC, Moshynska O, Kanthan R, Boctor MA (2004) Clonal B cell populations in a minority of patients with Hashimoto\u2019s thyroiditis. J Clin Pathol 57: 1258\u20131263.","DOI":"10.1136\/jcp.2004.018416"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Chen HI, Akpolat I, Mody DR, Lopez-Terrada D, De Leon AP, et al. (2006) Restricted kappa\/lambda light chain ratio by flow cytometry in germinal center B cells in Hashimoto thyroiditis. Am J Clin Pathol 125: 42\u201348.","DOI":"10.1309\/1G5F902YE7DDUNMA"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Zeppa P, Vitale M (2014) Fine needle cytology and flow cytometry in Hashimoto thyroiditis and primary thyroid lymphoma. Acta Cytol 58: 318.","DOI":"10.1159\/000360067"},{"key":"39","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1182\/blood.V96.3.808","volume":"96","author":"TG Willis","year":"2000","unstructured":"39 Willis TG, Dyer MJS (2000) The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood 96: 808\u2013822.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"40","doi-asserted-by":"publisher","unstructured":"40 K\u00fcppers R, Dalla-Favera R (2001) Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20: 5580\u20135594.","DOI":"10.1038\/sj.onc.1204640"},{"key":"41","unstructured":"41 Bernicot I, Douet-Guilbert N, Le Bris MJ, Morice P, Abgrall JF, et al. (2005) Characterization of IGH rearrangements in non-Hodgkin\u2019s B-cell lymphomas by fluorescence <i>in situ<\/i> hybridization. Anticancer Res 25: 3179\u20133182."},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Troppan K, Wenzl K, Neumeister P, Deutsch A (2015) Molecular pathogenesis of MALT lymphoma. Gastroenterol Res Pract 2015: 102656.","DOI":"10.1155\/2015\/102656"},{"key":"43","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1182\/blood.V93.11.3601","volume":"93","author":"J Dierlamm","year":"1999","unstructured":"43 Dierlamm J, Baens M, Wlodarska I, Stefanova-Ouzounova M, Hernandez JM, et al. (1999) The apoptosis inhibitor gene API2 and novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 93: 3601\u20133609.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"44","doi-asserted-by":"publisher","unstructured":"44 Streubel B, Simonisch-Klupp I, Mullauer L, Lamprecht A, Huber D, et al. (2004) Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia 18: 1722\u20131726.","DOI":"10.1038\/sj.leu.2403501"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Violeta Filip P, Cuciureanu D, Sorina Diaconu L, Maria Vladareanu A, Silvia Pop C (2018) MALT lymphoma: epidemiology, clinical diagnosis and treatment. J Med Life 11: 187\u2013193.","DOI":"10.25122\/jml-2018-0035"},{"key":"46","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/sj.leu.2403644","volume":"19","author":"B Streubel","year":"2005","unstructured":"46 Streubel B, Vinatzer U, Lamprecht A, Radere M, Chott A (2005) T (3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 19: 652\u2013658.","journal-title":"Leukemia","ISSN":"https:\/\/id.crossref.org\/issn\/0887-6924","issn-type":"print"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Nadal B, Marculescu R, Le T, Rudnicki M, B\u00f6csk\u00f6r S, et al. (2009) Novel insights into the mechanism of t(14;18)(q32;q21) translocation in follicular lymphoma. Leuk Lymphoma 42: 1181\u20131194.","DOI":"10.3109\/10428190109097743"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Taji S, Nomura K, Matsumoto Y, Sakabe H, Yoshida N, et al. (2005) Trisomy 3 may predict a poor response of gastric MALT lymphoma to <i>Helicobacter pylori<\/i> eradication therapy. World J Gastroenterol 11: 89\u201393.","DOI":"10.3748\/wjg.v11.i1.89"},{"key":"49","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1182\/blood.V85.8.2000.bloodjournal8582000","volume":"85","author":"AC Wotherspoon","year":"1995","unstructured":"49 Wotherspoon AC, Finn TM, Isaacson PG (1995) Trisomy 3 in low grade B-cell lymphomas of mucosa-associated lymphoid tissue. Blood 85: 2000\u20132004.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"50","unstructured":"50 Ott G, Katzenberger T, Greiner A, Kalla J, Rosenwald A, et al. (1997) The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin\u2019s lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res 57: 3944\u20133948."},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Remstein ED, Kurtin PJ, James CD, Wang XY, Meyer RG, et al. (2002) Mucosa-associated lymphoid tissue lymphomas with t(11;18)(q21;q21) and mucosa-associated lymphoid tissue lymphomas with aneuploidy develop along different pathogenetic pathways. Am J Pathol 161: 63\u201371.","DOI":"10.1016\/S0002-9440(10)64157-0"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/12\/66_EJ18-0348\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T05:44:15Z","timestamp":1664257455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/12\/66_EJ18-0348\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej18-0348","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}